ANRS, Emerging Infectious Diseases

🇫🇷France
Ownership
Private
Employees
-
Market Cap
-
Website

Third Line Antiretroviral Treatment Optimization in Sub-Saharan Africa

First Posted Date
2014-01-01
Last Posted Date
2017-02-17
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
201
Registration Number
NCT02025868
Locations
🇧🇫

CHU Yalgado Ouedraogo, Ouagadougou, Burkina Faso

🇧🇫

CHU Sourô Sanou, Bobo-Dioulasso, Burkina Faso

🇨🇮

Centre de Prise en Charge et de Formation (CePReF), Association ACONDA, Abidjan, Côte D'Ivoire

and more 4 locations

Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection

Phase 2
Conditions
Interventions
First Posted Date
2013-11-18
Last Posted Date
2017-07-11
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
105
Registration Number
NCT01986543
Locations
🇺🇬

Mbarara Research Base, Mbarara PO box 1956, Mbarara, Uganda

Therapeutic Option for Hepatitis B and C: a French Cohort

Active, not recruiting
Conditions
First Posted Date
2013-10-01
Last Posted Date
2023-01-31
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
20902
Registration Number
NCT01953458

X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2013-09-30
Last Posted Date
2015-07-01
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
90
Registration Number
NCT01952587
Locations
🇫🇷

Purpan Hospital, Toulouse, France

Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection

First Posted Date
2013-09-17
Last Posted Date
2016-02-02
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
699
Registration Number
NCT01944527
Locations
🇫🇷

Claire Fougerou, Rennes, France

IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2013-09-16
Last Posted Date
2019-04-30
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
26
Registration Number
NCT01942655
Locations
🇫🇷

Centre d'Investigation Clinique BT505, Hôpital Cochin, Paris, France

Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire

Completed
Conditions
First Posted Date
2013-08-06
Last Posted Date
2021-06-11
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
511
Registration Number
NCT01917175
Locations
🇨🇮

Centre Médical du Suivi des Donneurs de Sang (Blood Bank Medical Centre), Abidjan, Côte D'Ivoire

🇨🇮

Centre National de Transfusion Sanguine (National Blood Transfusion Centre), Abidjan, Côte D'Ivoire

Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa

First Posted Date
2013-07-23
Last Posted Date
2017-07-21
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
265
Registration Number
NCT01905059
Locations
🇧🇫

Day Care Center CHU Sanou Sauro, Bobo Dioulasso, Burkina Faso

🇨🇲

Central Hospital, Yaounde, Cameroon

🇸🇳

CRCF Hopital de Fann, Dakar, Senegal

and more 2 locations

Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2013-07-15
Last Posted Date
2016-07-06
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
24
Registration Number
NCT01899196
Locations
🇫🇷

Hospital St Antoine, Paris, France

Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread?

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2013-07-11
Last Posted Date
2018-02-27
Lead Sponsor
ANRS, Emerging Infectious Diseases
Registration Number
NCT01895920
Locations
🇫🇷

Service de Médecine Interne, CHU Kremlin-Bicêtre, Le Kremlin Bicêtre, France

© Copyright 2024. All Rights Reserved by MedPath